[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627269":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":33,"centralContacts":37,"locations":42,"responsibleParty":155,"collaborators":32,"id":157,"slug":158,"hasResults":159,"nctId":160,"briefTitle":161,"officialTitle":162,"acronym":32,"eligibilityCriteria":163,"healthyVolunteers":164,"sex":165,"minAge":166,"maxAge":167,"enrollmentInfo":168,"targetDuration":32,"studyType":171,"phases":172,"briefSummary":174,"conditions":175,"keywords":178,"overallStatus":45,"whyStopped":32,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":187,"completionDateStruct":189,"leadSponsor":191,"locationsCount":192},{"fullName":5,"class":6},"Vanda Pharmaceuticals","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo Group","PLACEBO_COMPARATOR","Treatment with placebo BID for approximately 2 weeks",[13],"Drug: Placebo",{"label":15,"type":16,"description":17,"interventionNames":18},"Tradipitant Group","EXPERIMENTAL","Treatment with tradipitant BID for approximately 2 weeks",[19],"Drug: Tradipitant",[21,29],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Tradipitant","Oral Capsule",[15],[27,28],"Nereus","VLY-686",{"type":22,"name":30,"description":24,"armGroupLabels":31,"otherNames":32},"Placebo",[9],null,[34],{"name":35,"affiliation":35,"role":36},"Vanda Pharmaceuticals Inc.","STUDY_DIRECTOR",[38],{"name":5,"role":39,"phone":40,"phoneExt":32,"email":41},"CONTACT","(202) 734-3400","clinicaltrials@vandapharma.com",[43,60,70,81,92,103,113,123,134,144],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Vanda Investigational Site","RECRUITING","Los Angeles","California","90025","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-118.24368,34.05223,{"lat":55,"lon":54},[58],{"name":5,"role":39,"phone":59,"phoneExt":32,"email":32},"202-734-3400",{"facility":44,"status":45,"city":61,"state":47,"zip":62,"country":49,"countryCode":50,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"San Diego","92108",{"type":52,"coordinates":64},[65,66],-117.16472,32.71571,{"lat":66,"lon":65},[69],{"name":5,"role":39,"phone":59,"phoneExt":32,"email":32},{"facility":44,"status":71,"city":72,"state":47,"zip":73,"country":49,"countryCode":50,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"NOT_YET_RECRUITING","San Jose","95124",{"type":52,"coordinates":75},[76,77],-121.89496,37.33939,{"lat":77,"lon":76},[80],{"name":5,"role":39,"phone":40,"phoneExt":32,"email":32},{"facility":44,"status":45,"city":82,"state":83,"zip":84,"country":49,"countryCode":50,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Tampa","Florida","33613",{"type":52,"coordinates":86},[87,88],-82.45843,27.94752,{"lat":88,"lon":87},[91],{"name":5,"role":39,"phone":40,"phoneExt":32,"email":32},{"facility":44,"status":71,"city":93,"state":94,"zip":95,"country":49,"countryCode":50,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Hamilton","New Jersey","08690",{"type":52,"coordinates":97},[98,99],-74.08125,40.20706,{"lat":99,"lon":98},[102],{"name":5,"role":39,"phone":40,"phoneExt":32,"email":32},{"facility":44,"status":71,"city":104,"state":104,"zip":105,"country":49,"countryCode":50,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"New York","10016",{"type":52,"coordinates":107},[108,109],-74.00597,40.71427,{"lat":109,"lon":108},[112],{"name":5,"role":39,"phone":59,"phoneExt":32,"email":32},{"facility":44,"status":71,"city":114,"state":104,"zip":115,"country":49,"countryCode":50,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Syosset","11791",{"type":52,"coordinates":117},[118,119],-73.50207,40.82621,{"lat":119,"lon":118},[122],{"name":5,"role":39,"phone":40,"phoneExt":32,"email":32},{"facility":44,"status":71,"city":124,"state":125,"zip":126,"country":49,"countryCode":50,"cosmosGeoPoint":127,"geoPoint":131,"contacts":132},"Plano","Texas","75024",{"type":52,"coordinates":128},[129,130],-96.69889,33.01984,{"lat":130,"lon":129},[133],{"name":5,"role":39,"phone":40,"phoneExt":32,"email":32},{"facility":44,"status":71,"city":135,"state":125,"zip":136,"country":49,"countryCode":50,"cosmosGeoPoint":137,"geoPoint":141,"contacts":142},"San Antonio","78215",{"type":52,"coordinates":138},[139,140],-98.49363,29.42412,{"lat":140,"lon":139},[143],{"name":5,"role":39,"phone":40,"phoneExt":32,"email":32},{"facility":44,"status":71,"city":145,"state":146,"zip":147,"country":49,"countryCode":50,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"Burke","Virginia","22015",{"type":52,"coordinates":149},[150,151],-77.27165,38.79345,{"lat":151,"lon":150},[154],{"name":5,"role":39,"phone":40,"phoneExt":32,"email":32},{"type":156,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR","100627269","phase-3-a-study-to-evaluate-tradipitant-on-treating-nausea-and-vomiting-induced-by-glp-1r-agonist-use-100627269",false,"NCT07446439","A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use","The Thetis Study: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Tradipitant on Nausea and Vomiting After GLP-1R Agonist Administration in Healthy Overweight or Obese Volunteers","Inclusion Criteria:\n\n* Body Mass Index ≥ 25 and \\\u003C 40 kg\u002Fm\\^2\n* No serious medical problems or chronic diseases, specifically no type I or type II diabetes\n\nExclusion Criteria:\n\n* Another disorder that contributes to gastrointestinal symptoms\n* History of intolerance and\u002For hypersensitivity to NK-1 receptor antagonists\n* History of intolerance and\u002For hypersensitivity to GLP-1 receptor agonists\n* Exposure to any investigational medication within the past 60 days",true,"ALL","18 Years","65 Years",{"count":169,"type":170},280,"ESTIMATED","INTERVENTIONAL",[173],"PHASE3","The goal of this study is to measure the effects of using Tradipitant to treat nausea and vomiting induced by GLP-1R agonist use in adults with class I or class II obesity, or adults who are overweight with at least one weight-related condition. The study is placebo-controlled with two treatment arms.",[176,177],"Nausea and Vomiting","Obesity",[179,180,181,182],"GLP-1R agonist","Semaglutide","Nausea","Vomiting","2026-04-14",{"date":185,"type":186},"2026-04-20","ACTUAL",{"date":188,"type":186},"2026-03-27",{"date":190,"type":170},"2026-12-01",{"name":5,"class":6},10]